<Disease><Name>ACUTE INTERMITTEND PORPHYRIA (AIP)</Name><Synonym>PORPHYRIA, ACUTE INTERMITTEND; PORPHYRIA, ACUTE INTERMITTEND</Synonym><OMIM><Number>176000</Number><URL>http://omim.org/entry/176000</URL></OMIM><Orphanet><Number>79276</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=79276</URL></Orphanet><Protein><Number>porphobilinogen deaminase</Number><URL>http://www.uniprot.org/uniprot/P08397</URL></Protein><ExPASy><Number>2.5.1.61</Number><URL>http://enzyme.expasy.org/EC/2.5.1.61</URL></ExPASy><Gene>11q23.3</Gene><ICD>E80.2</ICD><Summary>rare (1:10000-1:100000) ;autosomal dominant;mutation in the gene encoding hydroxymethylbilane synthase</Summary><Symptoms><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2323</id><symptom>behavior, abnormal or bizarre, confusion / behaviour, abnormal or bizarre</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3782</id><symptom>behavior, anxiety</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1923</id><symptom>coma</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1983</id><symptom>constipation</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1982</id><symptom>diarrhea</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1713</id><symptom>fever, severe or recurrent</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3475</id><symptom>hyperaesthesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2296</id><symptom>hypertension</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>3925</id><symptom>hyponatremia</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1998</id><symptom>liver involvement or dysfunction</symptom><category>GASTROINTESTINAL SYSTEM</category></symtomp><symtomp><id>1787</id><symptom>muscle weakness</symptom><category>MUSCLES</category></symtomp><symtomp><id>1981</id><symptom>nausea</symptom><category>GASTROINTESTINAL SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1975</id><symptom>pain, abdominal / pain abdominal</symptom><category>BODY | GENERAL TOPICS</category></symtomp><symtomp><id>2029</id><symptom>pain, muscle / myalgia, pain muscle</symptom><category>GENERAL TOPICS | MUSCLES</category></symtomp><symtomp><id>1938</id><symptom>paresthesia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3185</id><symptom>red colored urine</symptom><category>GENERAL TOPICS | GENITOURINARY TRACT</category></symtomp><symtomp><id>2143</id><symptom>respiratory insufficiency / respiratory failure</symptom><category>LUNG OR RESPIRATORY SYSTEM</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1934</id><symptom>sweating</symptom><category>GENERAL TOPICS | SKIN</category></symtomp><symtomp><id>3636</id><symptom>syndrome of inappropriate antidiuretic hormone (SIADH)</symptom><category>ENDOCRINE SYSTEM</category></symtomp><symtomp><id>2201</id><symptom>tachykardia / tachycardia</symptom><category>CARDIOVASCULAR SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3998</id><symptom>urine color, abnormal</symptom><category>GENITOURINARY TRACT</category></symtomp><symtomp><id>1980</id><symptom>vomiting</symptom><category>GASTROINTESTINAL SYSTEM | GENERAL TOPICS</category></symtomp></Symptoms><Metabolites><metabolite><id>1804</id><name>5-Aminolevulinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method>NMR</method><comment>?</comment></metabolite><metabolite><id>2091</id><name>5-Aminolevulinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>3.00</max><unit>mmol/mol creatinine</unit><age>Adolescence</age><method /><comment /></metabolite><metabolite><id>2138</id><name>Sodium</name><specimen>urine</specimen><value>increased</value><min>40.00</min><max>220.00</max><unit>mmol/24h</unit><age>ALL</age><method /><comment /></metabolite><metabolite><id>1860</id><name>5-Aminolevulinic acid</name><specimen>urine</specimen><value>increased</value><min>1.20</min><max>4.40</max><unit>mmol/mol creatinine</unit><age>Adulthood</age><method>NMR</method><comment>The Human Urine Metabolome</comment></metabolite><metabolite><id>1523</id><name>5-Aminolevulinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>12.00</max><unit>mmol/mol creatinine</unit><age>Childhood</age><method /><comment /></metabolite><metabolite><id>1174</id><name>5-Aminolevulinic acid</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>20.00</max><unit>mmol/mol creatinine</unit><age>Neonatal</age><method /><comment /></metabolite><metabolite><id>1012</id><name>Magnesium</name><specimen>serum</specimen><value>decreased</value><min>0.70</min><max>1.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>1184</id><name>Porphobilinogen (PBG)</name><specimen>urine</specimen><value>increased</value><min>0.00</min><max>1.40</max><unit>mmol/mol creatinine</unit><age>all</age><method /><comment /></metabolite><metabolite><id>1185</id><name>Porphyrins</name><specimen>urine</specimen><value>increased</value><min>    </min><max>    </max><unit>not detectable</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1192</id><name>Porphyrins</name><specimen>fecal</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1193</id><name>Porphyrins</name><specimen>plasma</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>1194</id><name>Porphyrins</name><specimen>erythrocytes</specimen><value>increased</value><min>    </min><max>    </max><unit>no data</unit><age>no data</age><method /><comment /></metabolite><metabolite><id>409</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>134.00</min><max>146.00</max><unit>mmol/l</unit><age>newborn</age><method /><comment /></metabolite><metabolite><id>413</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>infant</age><method /><comment /></metabolite><metabolite><id>728</id><name>Sodium</name><specimen>sweat</specimen><value>decreased</value><min>20.00</min><max>30.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite><metabolite><id>1105</id><name>Sodium</name><specimen>serum</specimen><value>decreased</value><min>135.00</min><max>145.00</max><unit>mmol/l</unit><age>child</age><method /><comment /></metabolite></Metabolites><Literatures><literature><id>7944</id><title>Acute Intermittent Porphyria</title><author>Whatley SD,</author><journal>GeneReviews&#174; [Internet]</journal><year>2020</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Badminton MN</co_aut></literature><literature><id>7952</id><title>Reversible splenial lesion syndrome (RESLES) due to acute intermittent porphyria with a novel mutation in the hydroxymethylbila</title><author>Yang J,</author><journal>Orphanet J Rare Dis</journal><year>2020</year><book /><volume>15</volume><number>1</number><pages>98</pages><co_aut>et al.</co_aut></literature><literature><id>4599</id><title>Hepatic porphyria: A narrative review</title><author>Arora S;</author><journal>Indian J Gastroenterol</journal><year>2016</year><book /><volume>35</volume><number>6</number><pages>405-418</pages><co_aut>et al.</co_aut></literature><literature><id>3542</id><title>[Influence of long-term treatment with hemin in the development of chronic renal failure in acute intermittent porphyria]</title><author>Garci&#161;a-Morillo JS,</author><journal>Med Clin (Barc)</journal><year>2015</year><book /><volume>146</volume><number>8</number><pages>373-374</pages><co_aut>Gonzalez-Estrada A, Rodriguez-Suarez S</co_aut></literature><literature><id>3543</id><title>Acute intermittent porphyria: comorbidity and shared familial risks with schizophrenia and bipolar disorder </title><author>Cederloef M,</author><journal>Br J Psychiatry</journal><year>2015</year><book /><volume>207</volume><number>6</number><pages>556-557</pages><co_aut>et al.</co_aut></literature><literature><id>3544</id><title>Porphyric neuropathies in an acute intermittent porphyria family</title><author>Kuo HC,</author><journal>Neuropathology</journal><year>2015</year><book /><volume>36</volume><number>3</number><pages>290-294</pages><co_aut>et al.</co_aut></literature><literature><id>3545</id><title>Challenges in the successful management of a case of acute intermittent porphyria in India</title><author>Patell R,</author><journal>Trop Doct</journal><year>2015</year><book /><volume>46</volume><number>3</number><pages>150-153</pages><co_aut>et al.</co_aut></literature><literature><id>3546</id><title>Abdominal pain and syndrome of inappropriate antidiuretic hormone secretion as clinical presentation of acute intermittent porp</title><author>Valle Feijoo ML,</author><journal>Rev Clin Esp</journal><year>2015</year><book /><volume>215</volume><number>6</number><pages>349-351</pages><co_aut>et al.</co_aut></literature><literature><id>3547</id><title>An update of clinical management of acute intermittent porphyria</title><author>Pischik E,</author><journal>Appl Clin Genet</journal><year>2015</year><book /><volume>8</volume><number>0</number><pages>201-214</pages><co_aut>Kauppinen R</co_aut></literature><literature><id>3548</id><title>Liver transplantation in the management of porphyria</title><author>Singal AK,</author><journal>Hepatology</journal><year>2014</year><book /><volume>60</volume><number>3</number><pages>1082-1092</pages><co_aut>et al.</co_aut></literature><literature><id>3549</id><title>Porphyric neuropathy</title><author>Lin CS,</author><journal>Handb Clin Neurol</journal><year>2013</year><book /><volume>115</volume><number>0</number><pages>613-627</pages><co_aut>Park SB, Krishnan AV</co_aut></literature><literature><id>3133</id><title>Acute intermittent porphyria presenting solely with psychosis: a case report and discussion</title><author>Kumar B</author><journal>Psychosomatics</journal><year>2012</year><book /><volume>53</volume><number>5</number><pages>494-498</pages><co_aut /></literature><literature><id>3134</id><title>Acute intermittent porphyria--diagnostic and treatment traps</title><author>Cojocaru IM,</author><journal>Rom J Intern Med</journal><year>2012</year><book /><volume>50</volume><number>1</number><pages>33-41</pages><co_aut>et al.</co_aut></literature><literature><id>3135</id><title>Acute intermittent porphyria: fatal complications of treatment</title><author>Stein PE,</author><journal>Clin Med</journal><year>2012</year><book /><volume>12</volume><number>3</number><pages>293-294</pages><co_aut>et al.</co_aut></literature><literature><id>3136</id><title>Acute intermittent porphyria: a diagnostic challenge</title><author>Anyaegbu E,</author><journal>J Child Neurol</journal><year>2012</year><book /><volume>27</volume><number>7</number><pages>917-921</pages><co_aut>et al.</co_aut></literature><literature><id>3138</id><title>Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria</title><author>Frei P,</author><journal>Case Rep Gastroenterol</journal><year>2012</year><book /><volume>6</volume><number>1</number><pages>190-196</pages><co_aut>et al.</co_aut></literature><literature><id>3139</id><title>A LC-MS/MS method for the specific, sensitive, and simultaneous quantification of 5-aminolevulinic acid and porphobilinogen</title><author>Zhang J,</author><journal>J Chromatogr B Analyt Technol Biomed Life Sci</journal><year>2011</year><book /><volume>879</volume><number>24</number><pages>2389-2396</pages><co_aut>et al.</co_aut></literature><literature><id>3140</id><title>The acute hepatic porphyrias: current status and future challenges</title><author>Siegesmund M,</author><journal>Best Pract Res Clin Gastroenterol</journal><year>2010</year><book /><volume>24</volume><number>5</number><pages>593-605</pages><co_aut>et al.</co_aut></literature><literature><id>3137</id><title>Recommendations for the diagnosis and treatment of the acute porphyrias</title><author>Anderson KE,</author><journal>Ann Intern Med</journal><year>2005</year><book /><volume>142</volume><number>6</number><pages>439-450</pages><co_aut>et al.</co_aut></literature><literature><id>1388</id><title>Molecular analysis of acute intermittent porphyria: mutation screening in 20 patients in Germany reveals 11 novel mutations</title><author>Von Brasch L</author><journal>Blood Cells Mol Dis</journal><year>2004</year><book /><volume>32</volume><number>2</number><pages>309-314</pages><co_aut>et al.</co_aut></literature><literature><id>1389</id><title>Liver transplantation as a cure for acute intermittent porphyria</title><author>Soonawalla ZF</author><journal>Lancet</journal><year>2004</year><book /><volume>363</volume><number>0</number><pages>705-706</pages><co_aut>et al.</co_aut></literature><literature><id>1401</id><title>Molecular diagnostics of acute intermittent porphyria</title><author>Kauppinen R</author><journal>Expert Rev Mol Diagn</journal><year>2004</year><book /><volume>4</volume><number>2</number><pages>243-249</pages><co_aut /></literature><literature><id>1399</id><title>Use of gonadotropin-releasing hormone analog with tibolone to prevent cyclic attacks of acute intermittent porphyria</title><author>Castelo-Branco C</author><journal>Metabolism</journal><year>2001</year><book /><volume>50</volume><number>9</number><pages>995-996</pages><co_aut>et al.</co_aut></literature><literature><id>786</id><title>Porphyrias</title><author>Nordmann Y</author><journal>in Fernandes J, Saudubray JM, van den Berghe (eds): Inborn metabolic diseases, diagnosis and treatment; Berlin, Springer Verlag</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>333-340</pages><co_aut /></literature><literature><id>794</id><title>The porphyrias</title><author>Anderson KE</author><journal>Physicians guide to the laboratory diagnosis of metabolic diseases; Chapman &amp; Hall, London</journal><year>1996</year><book /><volume>0</volume><number>0</number><pages>437-451</pages><co_aut /></literature><literature><id>1400</id><title>A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria</title><author>Anderson KE</author><journal>Arch Intern Med</journal><year>1990</year><book /><volume>150</volume><number>7</number><pages>1469-1474</pages><co_aut>et al.</co_aut></literature></Literatures></Disease>